Identification of several genes differentially expressed during progression of chronic myelogenous leukemia

Leukemia

Volumn 12, Issue 3, 1998, Pages 326-332

  Daheron L ^a,b   Salmeron, S ^a   Patri, S ^a   Brizard, A ^a   Guilhot, F ^a   Chomel, J C ^a   Kitzis, A ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acute phase of CML; Chronic myelogenous leukemia (CML) progression; Laminin binding protein; MAZ; Ribosomal proteins; Subtractive library

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; MESSENGER RNA; RIBOSOME PROTEIN;

ARTICLE; BLAST CELL CRISIS; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; DNA PROBE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031932090     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400923     Document Type: Article

References (22)

1. McWhirter JR, Wang JYJ. Activation of tyrosine kinase and microfilament-binding functions of c-abl by her sequences in bcr/abl fusion proteins. Mol Cell Biol 1991; 11: 1553-1565.
2. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175-185.
3. Sawyers CL, Callahan W, Witte ON. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 1992; 70: 901-910.
4. Renshaw MW, McWhirter JR, Wang JYJ. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol 1995; 15: 1286-1293.
5. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038-2044.
6. bcr-abl protein. Proc Natl Acad Sci USA 1988; 85: 9312-9316.
7. Feinstein E, Cimino C, Gale RP, Canaani E. Initiation and progression of chronic myelogenous leukemia. Leukemia 1992; 6: 37-43.
8. Neubauer A, He M, Schmidt CA, Huhn D, Liu ET. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction-based techniques. Leukemia 1993; 7: 251-257.
9. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299.
10. 30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res 1991; 19: 7097-7104.
11. Yow H, Wong JM, Chen HS, Lee C, Steele CD, Chen LB. Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. Proc Natl Acad Sci USA 1988; 83: 6394-6398.
12. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW. Gene expression profiles in normal and cancer cells. Science 1997; 276: 1268-1272.
13. Bossone SA, Asselin C, Patel AJ, Marcu KB. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci USA 1992; 89: 7452-7456.
14. Frigerio JM, Berthézène P, Garrido P, Ortiz E, Barthellemy S, Vasseur S, Sastre B, Seleznieff I, Dagorn JC, lovanna JL. Analysis of 2166 clones from a human colorectal cancer cDNA library by partial sequencing. Hum Molec Genet 1995; 4: 37-43.
15. Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol 1991; 11: 3842-3849.
16. Kondoh N, Schweinfest CW, Henderson KW, Papas TS. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 1992; 52: 791-796.
17. Barnard GF, Staniunas RJ, Bao S, Mafune K, Steele CD, Gollan JL, Chen LB. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. Cancer Res 1992; 52: 3067-3072.
18. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for longterm in vitro hematopoiesis. Blood 1992; 79: 2821-2826.
19. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 1986; 83: 5306-5310.
20. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342-344.
21. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest 1992; 90: 1232-1241.
22. Bhatia R, McGlave PB, Verfaillie CM. Treatment of marrow stroma with interferon-α restores normal β1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. J Clin Invest 1995; 96: 931-939